Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,603 public trials 2,148 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Recruiting

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

NCT07383441

Conditions
Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +18 more
Locations
  • Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • Highlands Oncology Group - Rogers Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
View all 41 locations
View Trial Details
Recruiting

Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus

NCT06593392

Conditions
Chronic Disease, Chronic Kidney Diseases, Disease Attributes, +15 more
Locations
  • Sichuan University-West China Second University Hospital Chengdu, China
  • The First Affiliated Hospital, Sun Yat-sen University Guangzhou, China
  • Guangzhou Women and Children's Medical Center Guangzhou, China
  • The Children's Hospital Zhejiang University School of Medicine Hangzhou, China
View all 16 locations
View Trial Details
Recruiting

US Zamto-cel Autoimmune Diseases

NCT06708845

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +17 more
Locations
  • Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Recruiting

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

NCT07144319

Conditions
Bladder Cancer, Carcinoma, Female Urogenital Diseases, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Regents of the University of Michigan Ann Arbor, Michigan, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
  • Oslo University Hospital Oslo, Norway
View Trial Details
Recruiting

Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)

NCT06960577

Conditions
Cisplatin, Doxorubicin, Female Urogenital Diseases, +14 more
Locations
  • Research Site Chermside, Australia
  • Research Site Elizabeth Vale, Australia
  • Research Site Heidelberg, Australia
  • Research Site Hong Kong, Australia
View all 59 locations
View Trial Details

Related conditions